STAAR SURGICAL CO — Director's Dealing 2021

May 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-05-21

Reporting Person: Barnes Scott D (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-21	Common Stock	M	2500	$16.15	Acquired	25826	Direct
2021-05-21	Common Stock	M	2229	$35.98	Acquired	28055	Direct
2021-05-21	Common Stock	M	7566	$27.53	Acquired	35621	Direct
2021-05-21	Common Stock	D	12295	$126.05	Disposed	23326	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-21	Common Stock Options	$16.15	M	2500	Disposed	2028-03-14	Common Stock (2500)	Direct
2021-05-21	Common Stock Options	$35.98	M	2229	Disposed	2029-03-13	Common Stock (2229)	Direct
2021-05-21	Common Stock Options	$27.53	M	7566	Disposed	2030-03-19	Common Stock (7566)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.00 to $126.36, inclusive.

F2: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.

F3: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.